Abstract
With the aim to reduce dosing frequency and to target drugs to cellular compartments actually in need of treatment, the design of drug delivery systems is becoming complementary to new drug discovery. The review highlights various drug/antigen delivery approaches comprising of vesicular and particulate nanocarriers that are associated with spectacular advantages like improved solubility and stability for poorly soluble drugs, good safety profile, versatility for encapsulating nearly all drugs, drug-release modulation, high drug payloads etc. In this review, light is shed on the remarkable potential of nanotechnology to provide more effective therapeutic and prophylactic approaches for the treatment and prevention for HIV/AIDS.
Keywords: Antiretroviral, drug delivery, nanocarriers, particulate drug delivery, vesicular drug delivery.
Pharmaceutical Nanotechnology
Title:Nanocarrier based Antiretroviral Drug Delivery Approaches
Volume: 1 Issue: 4
Author(s): Sakshi Taneja and Kapil Khatri
Affiliation:
Keywords: Antiretroviral, drug delivery, nanocarriers, particulate drug delivery, vesicular drug delivery.
Abstract: With the aim to reduce dosing frequency and to target drugs to cellular compartments actually in need of treatment, the design of drug delivery systems is becoming complementary to new drug discovery. The review highlights various drug/antigen delivery approaches comprising of vesicular and particulate nanocarriers that are associated with spectacular advantages like improved solubility and stability for poorly soluble drugs, good safety profile, versatility for encapsulating nearly all drugs, drug-release modulation, high drug payloads etc. In this review, light is shed on the remarkable potential of nanotechnology to provide more effective therapeutic and prophylactic approaches for the treatment and prevention for HIV/AIDS.
Export Options
About this article
Cite this article as:
Taneja Sakshi and Khatri Kapil, Nanocarrier based Antiretroviral Drug Delivery Approaches, Pharmaceutical Nanotechnology 2013; 1 (4) . https://dx.doi.org/10.2174/22117385113016660007
DOI https://dx.doi.org/10.2174/22117385113016660007 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
Call for Papers in Thematic Issues
Polymeric nanocarriers in drug delivery
Polymeric nanocarriers play a crucial role in drug delivery due to their versatility, and unique properties for targeting and modifying drug release. Their ability to enhance therapeutic outcomes, reduce side effects, and enable the delivery of drugs in a more targeted and controlled manner made them popular in the last ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May be Important to Disease Etiology
Current Molecular Medicine DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Mini-Reviews in Medicinal Chemistry A Review of Pharmacological and Phytochemical Studies on Convolvulaceae Species <i>Rivea</i> and <i>Ipomea</i>
Current Traditional Medicine Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
Current Drug Metabolism Lanthionine Synthetase Component C-Like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes
Current Drug Targets Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Current Nanoscience Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier
Current HIV Research Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases
Current Cancer Drug Targets Retroviral Protein Transfer: Falling Apart to Make an Impact
Current Gene Therapy Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry Alteration of the Proline at Position 7 of the HIV-1 Spacer Peptide p1 Suppresses Viral Infectivity in a Strain Dependent Manner
Current HIV Research Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Agonists and Antagonists of Protease Activated Receptors (PARs)
Current Medicinal Chemistry Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Current Medicinal Chemistry Hereditary Papillary Renal Carcinoma Type I
Current Molecular Medicine Contribution of Poly(Amino Acids) to Advances in Pharmaceutical Biotechnology
Current Pharmaceutical Biotechnology Novel Colchicine Derivatives and their Anti-cancer Activity
Current Topics in Medicinal Chemistry Brachytherapy: State of the Art and Possible Improvements
Anti-Cancer Agents in Medicinal Chemistry Overview of the Structure and Function of Protein Kinases
Current Enzyme Inhibition